Hospital
University Health Services,inc
University Health Services,inc was paid $2.31M by Medicaid between Jan 2018 and Dec 2024, across 99 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 28% of everything it billed.
33Billing provider infoUNIVERSITY HEALTH SERVICES,INC
AUGUSTA, GA 30901
AUGUSTA, GA 30901
33aNPI1588665566assigned 08/02/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.31M
24GClaims143,757
24DCodes billed99
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Georgia
Rank by total paid#7 of 34
Median peer was paid$23K
This provider vs. median100×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,730 | $449K | |
| 2019 | 27,505 | $449K | |
| 2020 | 18,276 | $288K | |
| 2021 | 23,493 | $347K | |
| 2022 | 23,661 | $400K | |
| 2023 | 14,677 | $276K | |
| 2024incomplete | 9,415 | $99K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 28% | 15,504 | 11,314 | $655K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9.5% | 3,341 | 2,296 | $218K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 1,548 | 1,386 | $190K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.6% | 8,006 | 6,984 | $176K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.8% | 2,630 | 2,116 | $156K |
| 81001 | 5.0% | 6,594 | 5,757 | $114K | |
| 80053 | Comprehensive metabolic panel | 4.7% | 12,446 | 10,077 | $108K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.3% | 3,282 | 2,829 | $99K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 5,723 | 5,077 | $94K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.6% | 1,179 | 959 | $82K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 813 | 702 | $44K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 2,167 | 1,972 | $35K |
87 more codes
| 99285 | Emergency room visit (most serious) | 1.5% | 1,546 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 1,675 | $34K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.3% | 840 | $30K |
| 84703 | 1.0% | 2,260 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,796 | $19K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 604 | $17K |
| 87400 | <1% | 428 | $15K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,161 | $14K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 305 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 243 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,419 | $11K |
| 93296 | <1% | 357 | $11K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,094 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,187 | $9K |
| 85610 | <1% | 1,817 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,619 | $9K |
| 87077 | <1% | 809 | $7K | |
| 81003 | <1% | 1,145 | $7K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 211 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 190 | $5K |
| 82565 | <1% | 42 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 80 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,720 | $3K |
| 82948 | <1% | 12 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,404 | $2K |
| 86850 | <1% | 489 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 490 | $2K |
| 85027 | <1% | 1,918 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,113 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 68 | $1K |
| 82947 | <1% | 124 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 51 | $1K |
| 84484 | <1% | 4,978 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 785 | $1K |
| 87081 | <1% | 30 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,158 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 120 | $901.98 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,359 | $856.20 |
| 83735 | <1% | 1,144 | $839.03 | |
| 84702 | <1% | 1,244 | $623.48 | |
| 80061 | Lipid panel | <1% | 1,191 | $592.87 |
| G0378 | Hospital observation service, per hour | <1% | 57 | $591.26 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $342.80 |
| 83615 | <1% | 194 | $292.95 | |
| 83880 | <1% | 1,175 | $279.54 | |
| 87070 | <1% | 12 | $272.16 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 267 | $268.57 |
| 86780 | <1% | 41 | $237.83 | |
| 82607 | <1% | 187 | $195.47 | |
| 87631 | <1% | 330 | $179.27 | |
| 83690 | <1% | 3,505 | $176.59 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 13 | $167.16 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 14 | $136.60 |
| 84439 | <1% | 56 | $108.86 | |
| 86900 | <1% | 859 | $107.47 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,637 | $72.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,445 | $53.57 |
| 86140 | <1% | 57 | $31.67 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 681 | $30.08 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 737 | $25.00 |
| 86901 | <1% | 861 | $22.63 | |
| 85730 | <1% | 386 | $7.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,858 | $7.38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 522 | $5.90 |
| 87186 | <1% | 690 | $5.37 | |
| 81025 | <1% | 45 | $3.00 | |
| 84100 | <1% | 384 | $2.71 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 920 | $0.00 |
| 83605 | 0% | 353 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 777 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 486 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 30 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 56 | $0.00 |
| 82746 | 0% | 12 | $0.00 | |
| 36000 | 0% | 18 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 14 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 18 | $0.00 |
| 96376 | 0% | 55 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 14 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 28 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 22 | $0.00 |
| 84550 | 0% | 256 | $0.00 | |
| 76937 | 0% | 114 | $0.00 | |
| 82570 | 0% | 18 | $0.00 | |
| 82805 | 0% | 14 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 20 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCROSS, ROBERT (VP, GOVERNMENT REIMBURSEMENT)
Parent organizationUNIVERSITY HEALTH INC
| Provider | Location | Paid |
|---|---|---|
| The Medical Center INC | Columbus, GA | $1.18M |
| Piedmont Hospital, INC | Atlanta, GA | $542K |
| Eastside Medical Center, LLC | Snellville, GA | $2K |
| Piedmont Henry Hospital, INC. | Stockbridge, GA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.